Mölnlycke Health Care invests $8 million in Siren
Siren aims to reduce the risk of diabetic foot ulcers through early detection of potential damage using temperature-sensing textile technology used in socks.
"Our strategic investment in Siren reflects our commitment to integrate into digital ecosystems and develop innovative digital solutions that revolutionize healthcare," said Mölnlycke CEO Zlatko Rihter.
Go to the original article.
Contact us to request a correction